KAS
FBIO icon

Kestra Advisory Services’s Fortress Biotech FBIO Stock Holding History

Kestra Advisory Services’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
116,235
-13,566
-10% -$35K ﹤0.01% 2608
2026
Q1 		$362K Sell
129,801
-45,875
-26% -$156K ﹤0.01% 2470
2025
Q4 		$643K Sell
175,676
-21,199
-11% -$60.4K ﹤0.01% 1962
2025
Q3 		$727K Sell
196,875
-135,123
-41% -$342K ﹤0.01% 1809
2025
Q2 		$618K Buy
331,998
+39,517
+14% +$68.4K ﹤0.01% 1830
2025
Q1 		$456K Buy
292,481
+66,250
+29% +$117K ﹤0.01% 1866
2024
Q4 		$458K Buy
+226,231
New +$410K ﹤0.01% 1934
2023
Q4 		– Sell
-2,960
Closed -$12.9K – 2296
2023
Q3 		$12.9K Sell
2,960
-3,670
-55% -$25.2K ﹤0.01% 2094
2023
Q2 		$54.7K Sell
6,630
-767
-10% -$7.59K ﹤0.01% 2043
2023
Q1 		$91K Sell
7,397
-2,980
-29% -$35.5K ﹤0.01% 1962
2022
Q4 		$102K Sell
10,377
-126
-1% -$1.4K ﹤0.01% 2136
2022
Q3 		$135K Buy
10,503
+96
+0.9% +$1.44K ﹤0.01% 1936
2022
Q2 		$131K Sell
10,407
-296
-3% -$4.39K ﹤0.01% 1955
2022
Q1 		$218K Sell
10,703
-685
-6% -$18.8K ﹤0.01% 1798
2021
Q4 		$427K Buy
11,388
+4
+0% +$178 ﹤0.01% 1400
2021
Q3 		$550K Buy
11,384
+333
+3% +$16.3K 0.01% 1336
2021
Q2 		$592K Sell
11,051
-200
-2% -$12.1K 0.01% 1197
2021
Q1 		$596K Sell
11,251
-863
-7% -$48.7K 0.01% 1109
2020
Q4 		$618K Buy
12,114
+513
+4% +$22.2K 0.01% 1093
2020
Q3 		$703K Buy
+11,601
New +$591K 0.01% 739

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Kestra Advisory Services's FBIO Position: Q2 2026 in Review

Kestra Advisory Services reduced its Fortress Biotech (FBIO) stake by 10% in Q2 2026, selling an estimated $35K and leaving 116,235 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Kestra Advisory Services first reported a position in FBIO in Q3 2020 and has held it in 20 quarters since. The position peaked at $727K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Kestra Advisory Services held 116,235 shares of Fortress Biotech worth $356K as of Q2 2026.
  • Kestra Advisory Services sold 13,566 Fortress Biotech shares in Q2 2026, an estimated $35K.
  • Fortress Biotech made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2608 holding.
  • Kestra Advisory Services first reported a position in Fortress Biotech in Q3 2020 and has held it in 20 quarters since.
  • Kestra Advisory Services's Fortress Biotech position peaked at $727K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.